Jefferies Financial Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677K Sell
50,000
-1,950
-4% -$23.3K ﹤0.01% 1147
2026
Q1
$311K Buy
+51,950
New +$391K ﹤0.01% 1369
2023
Q3
Sell
-100,000
Closed -$2.08M 1879
2023
Q2
$2.08M Buy
+100,000
New +$2.17M 0.02% 646
2023
Q1
Sell
-70,000
Closed -$1.96M 1883
2022
Q4
$1.96M Buy
+70,000
New +$1.79M 0.01% 660

Other funds holding OGN

Jefferies Financial Group's OGN Position: Q2 2026 in Review

Jefferies Financial Group reduced its Organon & Co (OGN) stake by 3.8% in Q2 2026, selling an estimated $23.3K and leaving 50,000 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #1147.

Jefferies Financial Group first reported a position in OGN in Q4 2022 and has held it in 4 quarters since. The position peaked at $2.08M in Q2 2023. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Jefferies Financial Group held 50,000 shares of Organon & Co worth $677K as of Q2 2026.
  • Jefferies Financial Group sold 1,950 Organon & Co shares in Q2 2026, an estimated $23.3K.
  • Organon & Co made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1147 holding.
  • Jefferies Financial Group first reported a position in Organon & Co in Q4 2022 and has held it in 4 quarters since.
  • Jefferies Financial Group's Organon & Co position peaked at $2.08M in Q2 2023.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.